Access the full text.
Sign up today, get DeepDyve free for 14 days.
Y. Tsai, M. Hsieh, Chee-Jen Chang, Y. Wen, Han-Chung Hu, Y. Chao, Yhu-Chering Huang, Cheng-Ta Yang, Chung-Chi Huang (2015)
The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.Vaccine, 33 25
(1995)
Prevention (CDC)Increasing pneumococcal vaccination rates among patients of a National Health-Care Alliance-United States
M. Mirsaeidi, G. Ebrahimi, M. Allen, S. Aliberti (2014)
Pneumococcal vaccine and patients with pulmonary diseases.The American journal of medicine, 127 9
B. Lamprecht, M. McBurnie, W. Vollmer, G. Gudmundsson, T. Welte, E. Nizankowska-Mogilnicka, M. Studnicka, E. Bateman, J. Antó, P. Burney, D. Mannino, S. Buist (2011)
COPD in Never SmokersChest, 139
A. López-de-Andrés, P. Carrasco-Garrido, V. Hernández-Barrera, Á. Miguel, R. Jiménez-García (2007)
Coverages and factors associated with influenza vaccination among subjects with chronic respiratory diseases in Spain.European journal of public health, 18 2
(1995)
Increasing pneumococcal vaccination rates among patients of a National Health-Care Alliance—United StatesMMWR Morb Mortal Wkly Rep, 44
C. Reynolds, V. Snow, A. Qaseem, Lia Verbonitz (2008)
Improving Immunization Rates: Initial Results From a Team-Based, Systems Change ApproachAmerican Journal of Medical Quality, 23
Fang Xu, M. Town, L. Balluz, William Bartoli, W. Murphy, Pranesh Chowdhury, W. Garvin, Carol Pierannunzi, Yuna Zhong, Simone Salandy, Candace Jones, C. Crawford (2013)
Surveillance for certain health behaviors among States and selected local areas - United States, 2010.Morbidity and mortality weekly report. Surveillance summaries, 62 1
J. Juang, C. Chen, Ying-Hsiang Chen, I. Wu, Chih-Cheng Hsu, Leilei Chen, F. Tang, Chi-Chung Wang, C. Juan, H. Chiu, H. Lo, I. Chang, Juey-Jen Hwang, L. Lai, F. Chiang, Jiunn-lee Lin, C. Hsiung (2015)
Prevalence and prognosis of Brugada electrocardiogram patterns in an elderly Han Chinese population: a nation-wide community-based study (HALST cohort).Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 17 Suppl 2
KimDK, RileyLE, HarrimanKH (2017)
Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older – United States, 2017MMWR Morb Mortal Wkly Rep, 66
T. Yang, Eunsung Kim, Young-Joon Park, Dongwook Kim, Y. Kwon, J. Shin, O. Park (2016)
Successful introduction of an underutilized elderly pneumococcal vaccine in a national immunization program by integrating the pre-existing public health infrastructure.Vaccine, 34 13
Á. Domínguez, N. Soldevila, D. Toledo, N. Torner, L. Force, M. Pérez, V. Martín, L. Rodríguez-Rojas, J. Astray, M. Egurrola, F. Sanz, J. Castilla (2017)
Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in SpainPLoS ONE, 12
Chang-Hua Chen, Mingbin Wu, W. Hsu, Yu-Min Chen, Chih-Cheng Hsu, C. Hsiung, I. Wu (2017)
Determinants of influenza vaccination in older adults: A nationwide community‐based study in TaiwanGeriatrics & Gerontology International, 17
I. Hung, A. Leung, D. Chu, D. Leung, Terence Cheung, C. Chan, C. Lam, Shao-Haei Liu, C. Chu, P. Ho, S. Chan, T. Lam, R. Liang, K. Yuen (2010)
Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 51 9
H. Kerstjens, D. Postma (2002)
Chronic obstructive pulmonary disease.Clinical evidence, 7
J. Walters, Joanne Tang, P. Poole, R. Wood‐Baker (2017)
Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.The Cochrane database of systematic reviews, 1
E. Rouveix, D. Cherni, C. Dupont, A. Beauchet, H. Guepet, G. Gavazzi, J. Gaillat, Société clinique, Sggc (2013)
Streptococcus pneumoniae vaccinal coverage in hospitalized elderly patients in France.Medecine et maladies infectieuses, 43 1
D. Martinelli, S. Tafuri, G. Caputi, F. Fortunato, Paolo Reggio, C. Germinario, R. Prato (2010)
Eight years of active proposal of pneumococcal 23-valent polysaccharide vaccine: survey on coverage rate among elderly and chronic patients.American journal of infection control, 38 4
A. Vila-Córcoles, O. Ochoa-Gondar (2013)
Preventing Pneumococcal Disease in the ElderlyDrugs & Aging, 30
J. Massarelli (1984)
Harrison's Principles of Internal MedicineJAMA, 251
ReillyJJ, SilvermanEK, ShapiroSD, KasperD, FauciA, HauserS, LongoD, JamesonJL, LoscalzoJ (2015)
Chronic obstructive pulmonary diseaseHarrison's Principles of Internal Medicine, 19e
Mahoney Fi, Barthel Dw (1965)
FUNCTIONAL EVALUATION: THE BARTHEL INDEX.Maryland state medical journal, 14
Motoi Suzuki, B. Dhoubhadel, T. Ishifuji, M. Yasunami, Makito Yaegashi, N. Asoh, M. Ishida, Sugihiro Hamaguchi, M. Aoshima, K. Ariyoshi, K. Morimoto (2017)
Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study.The Lancet. Infectious diseases, 17 3
W. Liao, S. Lin, C. Lai, C.-K. Tan, C. Liao, Y. Huang, C.-Y. Wang, P. Hsueh (2010)
Impact of pneumococcal vaccines on invasive pneumococcal disease in TaiwanEuropean Journal of Clinical Microbiology & Infectious Diseases, 29
B. Lamprecht, M. McBurnie, W. Vollmer, G. Gudmundsson, T. Welte, E. Nizankowska-Mogilnicka, M. Studnicka, E. Bateman, J. Antó, P. Burney, D. Mannino, S. Buist (2011)
Results From the Population-Based Burden of Obstructive Lung Disease Study
A. Nunn, I. Gregg (1989)
New regression equations for predicting peak expiratory flow in adults.British Medical Journal, 298
ChowdhuryPP, BalluzL, MurphyW (2007)
Surveillance of certain health behaviors among states and selected local areas–United States, 2005MMWR Surveill Summ, 56
D. Kim, L. Riley, K. Harriman, P. Hunter, C. Bridges (2017)
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2017American Journal of Transplantation, 17
Miwako Kobayashi, N. Bennett, R. Gierke, O. Almendares, M. Moore, C. Whitney, T. Pilishvili (2015)
Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR. Morbidity and mortality weekly report, 64 34
P. Lu, J. Nuorti (2010)
Pneumococcal polysaccharide vaccination among adults aged 65 years and older, U.S., 1989-2008.American journal of preventive medicine, 39 4
T. Chan, I. Hung, J. Luk, Y. Shea, F. Chan, Patrick Woo, L. Chu (2012)
Prevention of mortality and pneumonia among nursing home older adults by dual pneumococcal and seasonal influenza vaccination during a pandemic caused by novel pandemic influenza A (H1N1).Journal of the American Medical Directors Association, 13 8
A. Jithoo, P. Enright, P. Burney, A. Buist, E. Bateman, W. Tan, M. Studnicka, F. Mejza, Suzanne Gillespie, W. Vollmer (2012)
Case-finding options for COPD: results from the Burden of Obstructive Lung Disease StudyEuropean Respiratory Journal, 41
M. Lawton, E. Brody (1969)
Assessment of older people: self-maintaining and instrumental activities of daily living.The Gerontologist, 9 3
AbstractOlder adults, particularly those with chronic obstructive pulmonary disease, are advised to receive 23-valent pneumococcal polysaccharide vaccine (PPV23). However, the PPV23 vaccination rate in Taiwan and the determinants of receipt remain unclear.We analyzed the data of 1475 community-dwelling older adults aged ≥75 years who participated in the Healthy Aging Longitudinal Study in Taiwan. Each participant received assessments of PPV23 status, sociodemographic factors (age, sex, education level, marital status, living alone, and occupation), and health-related factors (chronic diseases, smoking status, alcohol intake, physical activities, cognitive status, and physical performance). PPV23 rate was defined as the number of participants who reported receiving free PPV23 divided by the total number of candidates for free PPV23. Multinomial logistic regression analysis was applied to investigate the sociodemographic and health-related determinants of PPV23 status.A PPV23 vaccination rate of 20.7% (305/1475) was observed. Participants who were female, current smokers, and had a low peak expiratory flow were associated with PPV23 nonreceipt (all P <.05). Of the participants who had a low peak expiratory flow, low education status, and physical inactivity were associated with PPV23 nonreceipt (all P <.05).The PPV23 vaccination rate among adults aged ≥75 years was low. Older adults who were women, current smokers, or who had a low PEF were less likely to receive the PPV23. These findings support continual efforts to improve the PPV23 coverage rate in vulnerable populations.
Medicine – Wolters Kluwer Health
Published: Feb 1, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.